
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
[ Wed, Aug 01st 2018 ]: WOPRAI
Matthew Harrison Upgraded (SRPT) to Buy on, Aug 1st, 2018


🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Upgraded "Sarepta Therapeutics, Inc." (SRPT) to Buy on, Aug 1st, 2018.
Matthew has made no other calls on SRPT in the last 4 months.
There are 8 other peers that have a rating on SRPT. Out of the 8 peers that are also analyzing SRPT, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Hartaj Singh of "Oppenheimer" Downgraded from Buy to Hold on, Friday, May 4th, 2018
These are the ratings of the 7 analyists that currently disagree with Matthew
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $202 on, Thursday, June 21st, 2018
- Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $205 on, Thursday, June 21st, 2018
- Joseph Schwartz of "Leerink Swann" Maintained at Buy with Increased Target to $196 on, Wednesday, June 20th, 2018
- Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $267 on, Tuesday, June 19th, 2018
- Yun Zhong of "BTIG" Initiated at Strong Buy and Held Target at $120 on, Friday, June 15th, 2018
- Gena Wang of "Barclays" Upgraded from Hold to Buy on, Friday, May 11th, 2018
- Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $92 on, Friday, May 4th, 2018
Similar Stocks and Investing Publications
[ Thu, Jun 21st 2018 ]: WOPRAI
[ Thu, Jun 21st 2018 ]: WOPRAI
[ Wed, Jun 20th 2018 ]: WOPRAI
[ Wed, Jun 20th 2018 ]: WOPRAI
[ Tue, Jun 19th 2018 ]: WOPRAI
[ Fri, Jun 15th 2018 ]: WOPRAI
[ Fri, May 11th 2018 ]: WOPRAI
[ Fri, May 04th 2018 ]: WOPRAI
[ Wed, Mar 21st 2018 ]: WOPRAI
[ Wed, Mar 14th 2018 ]: WOPRAI
[ Thu, Jan 04th 2018 ]: WOPRAI
[ Fri, Dec 01st 2017 ]: WOPRAI